Civic Intelligence

Pharmacotherapy Publications Inc

990 • Fiscal year 2016 • EIN 04-2720360

Jan 01, 2016 to Dec 31, 2016 • Filed on Apr 26, 2017

Organization ProfileWWW.PHARMACOTHERAPY.ORG

View Organization Page

13000 West 87th Street ParkwayLenexa, KS 66215

(913) 492-3311

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

28th percentile

0.02x

Higher debt load relative to assets than 28% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Liabilities / Revenue

34th percentile

0.05x

Higher debt load relative to revenue than 34% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Net Margin

87th percentile

34%

Higher net margin than 87% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Top Officer Pay

35th percentile

$0

Higher top officer pay than 35% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2016

Asset Growth

73rd percentile

11%

Faster asset growth than 73% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Revenue Growth

83rd percentile

30%

Faster revenue growth than 83% of similar nonprofits.

2016 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2015 to 2016

Balance Sheet
Liabilities / Assets28th percentile

Assets

Up

$1,370,536

Up $132,141 (+11%) from 2015

Net Assets

Up

$1,349,797

Up $125,991 (+10%) from 2015

Liabilities

Up

$20,739

Up $6,150 (+42%) from 2015

Revenue And Expenses
Liabilities / Revenue34th percentileNet Margin87th percentile

Revenue

Up

$452,882

Up $105,468 (+30%) from 2015

Expenses

Up

$298,818

Up $46,350 (+18%) from 2015

Net Income

Up

$154,064

Up $59,118 (+62%) from 2015

Historical Trend

Balance Sheet Trend

Asset Growth73rd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$6.0M$4.0M$2.0M$0Assets 2010: $1,239,045Liabilities 2010: $188,429Net Assets 2010: $1,050,6162010Assets 2011: $1,082,574Liabilities 2011: $48,630Net Assets 2011: $1,033,9442011Assets 2012: $892,073Liabilities 2012: $98,983Net Assets 2012: $793,0902012Assets 2013: $1,041,494Liabilities 2013: $9,500Net Assets 2013: $1,031,9942013Assets 2014: $1,214,923Liabilities 2014: $30,000Net Assets 2014: $1,184,9232014Assets 2015: $1,238,395Liabilities 2015: $14,589Net Assets 2015: $1,223,8062015Assets 2016: $1,370,536Liabilities 2016: $20,739Net Assets 2016: $1,349,7972016Assets 2017: $1,637,402Liabilities 2017: $253,002Net Assets 2017: $1,384,4002017Assets 2018: $1,415,161Liabilities 2018: $218,665Net Assets 2018: $1,196,4962018Assets 2019: $1,510,021Liabilities 2019: $185,942Net Assets 2019: $1,324,0792019Assets 2020: $1,613,717Liabilities 2020: $147,715Net Assets 2020: $1,466,0022020Assets 2021: $1,752,757Liabilities 2021: $119,779Net Assets 2021: $1,632,9782021Assets 2022: $1,471,268Liabilities 2022: $99,821Net Assets 2022: $1,371,4472022Assets 2023: $1,560,881Liabilities 2023: $65,744Net Assets 2023: $1,495,1372023Assets 2024: $5,236,664Liabilities 2024: $229,370Net Assets 2024: $5,007,2942024

Highlighted filing

2016

Assets$1,370,536
Liabilities$20,739
Net Assets$1,349,797
Open 2016 Filing

Operations Trend

Revenue Growth83rd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2010: $981,3312010Expenses 2011: $1,002,8852011Revenue 2012: $421,035Expenses 2012: $701,815Net Income 2012: -$280,7802012Revenue 2013: $375,686Expenses 2013: $198,354Net Income 2013: $177,3322013Revenue 2014: $389,894Expenses 2014: $221,393Net Income 2014: $168,5012014Revenue 2015: $347,414Expenses 2015: $252,468Net Income 2015: $94,9462015Revenue 2016: $452,882Expenses 2016: $298,818Net Income 2016: $154,0642016Revenue 2017: $392,636Expenses 2017: $380,862Net Income 2017: $11,7742017Revenue 2018: $405,982Expenses 2018: $433,446Net Income 2018: -$27,4642018Revenue 2019: $384,308Expenses 2019: $444,198Net Income 2019: -$59,8902019Revenue 2020: $371,617Expenses 2020: $346,666Net Income 2020: $24,9512020Revenue 2021: $429,740Expenses 2021: $401,086Net Income 2021: $28,6542021Revenue 2022: $429,590Expenses 2022: $434,953Net Income 2022: -$5,3632022Revenue 2023: $406,984Expenses 2023: $475,737Net Income 2023: -$68,7532023Revenue 2024: $648,554Expenses 2024: $581,263Net Income 2024: $67,2912024

Highlighted filing

2016

Revenue$452,882
Expenses$298,818
Net Income$154,064
Open 2016 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2016 to Dec 31, 2016
Signed
Apr 26, 2017
Return Version
2016v3.0
Gross Receipts
$1,022,973
Mission and Program Overview

Mission

The organization's primary mission is to serve subscribers and the general public with education, review and publication of research and study results of drugs and the interaction of pharmaceuticals.

To serve subscribers and the general public with education, review, and publication of research and study results of drugs and the interaction of pharmaceuticals.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$846,011$896,635▲ $50,624
Cash and Non-Interest-Bearing Accounts$190,325$262,738▲ $72,413
Savings and Temporary Cash Investments$202,059$210,783▲ $8,724
Prepaid Expenses and Deferred Charges-$380-
Total Assets$1,238,395$1,370,536▲ $132,141
Liabilities
Deferred Revenue-$20,000-
Accounts Payable and Accrued Expenses$14,589$739▼ $13,850
Total Liabilities$14,589$20,739▲ $6,150
Net Assets / Fund Balance
Unrestricted Net Assets$1,223,806$1,349,797▲ $125,991
Total Net Assets Fund Balance$1,223,806$1,349,797▲ $125,991
Total Liabilities and Net Assets / Fund Balance$1,238,395$1,370,536▲ $132,141
Compensation and Service Providers
Top Officer Pay35th percentile

Board Members and Trustees

NameTitle
Edith a Nutescupharmd Ms FccpChair
C Lindsay Devane Pharm D Fccp BccpEx-officio
Brian a Hemstreet Pharm D FccpMember
Jerry L Bauman Pharmdfccp BcpsMember
William a Miller Pharm D Fccp FashpMember
Leigh Ann Ross Pharm D Fccp BcpsMember (form
Michael S Maddux Pharmd FccpSecretary-tr
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$353,749
Investment Income
$99,133
Other Revenue
$0
Change in Net Assets
$154,064

Audited Revenue Reconciliation

Revenue per Audited Statements
$441,170
Revenue Not Reported on Financial Statements
$11,712
Revenue Not Reported on Form 990
$-87,421
Total Revenue per Audited Statements
$353,749
Total Revenue per Form 990
$452,882
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$298,818
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$194,853$86,342-$281,195
Fees for Service Investment Mgmnt Fees-$11,712-$11,712
Fees for Services Accounting-$4,050-$4,050
Other Expenses$776$166-$166
Fees for Services Legal-$149-$149
Total Functional Expenses$195,629$103,189$0$298,818

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Form 990$298,818
Expenses per Audited Statements$287,106
Total Expenses per Audited Statements$287,106
Expenses Not Reported on Financial Statements$11,712
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
Yes
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“The return will be reviewed by the full board of directors. A copy of the return will be maintained for public inspection.”

Form 990, Page 6, Part VI, Line 12C

“The organization regularly monitors ongoing or proposed transactions for conflicts of interest as it relates to the board of directors. The policy prohibits participation and deliberation and decision making of any board member as it relates to a conflict.”

Form 990, Page 6, Part VI, Line 19

“Governing documents are available for public inspection upon request and posted on the secretary of state website of the commonwealth of massachussets.”

Filing and Contact Details

Filer

Filer Name
Pharmacotherapy Publications Inc
EIN
04-2720360
Phone
9134923311
Address
13000 WEST 87TH STREET PARKWAY, LENEXA, KS 66215

Signing Officer

Name
Michael S Maddux Pharmd Fccp
Title
Secretary-treasurer
Phone
9134923311
Signed
2017-04-26

Organization Details

Principal Officer
Michael S Maddux Pharmd Fccp
Formed
1981
Legal Domicile
Ma
Voting Board Members
5
Independent Board Members
4
Employees
0

Preparer

Firm
Bridgebuilder Tax Legal Services Pa
Address
9325 PFLUMM RD, LENEXA, KS 66215-3347
Preparer
Kenneth L Cox
Phone
9134926008
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Manuscript scientific editing 21,000 0 0 original manuscript fees 42,000 0 0 development editor & consulti 34,215 0 0 consulting 64,274 0 0 board of directors 0 44,426 0 scientific editors committee 9,031 0 0 overhead 0 33,805 0 contracted services 24,333 8,111 0 total 194,853 86,342 0”

Financial Statement Notes

Schedule D, Page 3, Part X

“Uncertain tax provisions, if any, are recorded in accordance with financial accounting standards board (fasb) accounting standards codification (asc) 740, income taxes, which require the recognition of a liability for tax positions taken that do not meet the more-likely-than-not standard that the position will be sustained upon examination by the taxing authorities. There is no liability for uncertain tax positions recorded at december 31. The organization's income tax filings are subject to examination by various taxing authorities. The organization's open examination periods are 2012 and forward.”

Raw XML Appendix383 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0true
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt014589
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0739
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0TO SERVE SUBSCRIBERS AND THE GENERAL PUBLIC WITH EDUCATION, REVIEW, AND PUBLICATION OF RESEARCH AND STUDY RESULTS OF DRUGS AND THE INTERACTION OF PHARMACEUTICALS.
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/AuditCommitteeInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ACCP-PHARMACOTHERAPY PUBLICATIONS
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine2Txt0INC
IRS990/BooksInCareOfDetail/PhoneNum09134923311
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt013000 WEST 87TH STREET PARKWAY
IRS990/BooksInCareOfDetail/USAddress/CityNm0LENEXA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0KS
IRS990/BooksInCareOfDetail/USAddress/ZIPCd066215
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0190325
IRS990/CashNonInterestBearingGrp/EOYAmt0262738
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt099133
IRS990/CYOtherExpensesAmt0298818
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt0353749
IRS990/CYRevenuesLessExpensesAmt0154064
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0298818
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0452882
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DeferredRevenueGrp/EOYAmt020000
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0SUBSCRIPTION SUPPLEMENTS AND PUBLICATION SUBSCRIPTIONS - ORGANIZATION PUBLISHES A MONTHLY SCIENTIFIC JOURNAL THAT CONTAINS CLINICAL RESEARCH ARTICLES AND PROVIDES EVALUATIONS OF DRUGS AND DRUG TREATMENTS.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0195629
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt04050
IRS990/FeesForServicesAccountingGrp/TotalAmt04050
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt0149
IRS990/FeesForServicesLegalGrp/TotalAmt0149
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt086342
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0194853
IRS990/FeesForServicesOtherGrp/TotalAmt0281195
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt011712
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt011712
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt32.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/PersonNm0MICHAEL S MADDUX PHARMD FCCP
IRS990/Form990PartVIISectionAGrp/PersonNm1WILLIAM A MILLER PHARM D FCCP FASHP
IRS990/Form990PartVIISectionAGrp/PersonNm2JERRY L BAUMAN PHARMDFCCP BCPS
IRS990/Form990PartVIISectionAGrp/PersonNm3EDITH A NUTESCUPHARMD MS FCCP
IRS990/Form990PartVIISectionAGrp/PersonNm4LEIGH ANN ROSS PHARM D FCCP BCPS
IRS990/Form990PartVIISectionAGrp/PersonNm5C LINDSAY DEVANE PHARM D FCCP BCCP
IRS990/Form990PartVIISectionAGrp/PersonNm6BRIAN A HEMSTREET PHARM D FCCP
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/TitleTxt0SECRETARY-TR
IRS990/Form990PartVIISectionAGrp/TitleTxt1MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt2MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt3CHAIR
IRS990/Form990PartVIISectionAGrp/TitleTxt4MEMBER (FORM
IRS990/Form990PartVIISectionAGrp/TitleTxt5EX-OFFICIO
IRS990/Form990PartVIISectionAGrp/TitleTxt6MEMBER
IRS990/Form990ProvidedToGvrnBodyInd0false
IRS990/FormationYr01981
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/SecuritiesAmt065024
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt0635115
IRS990/GrossReceiptsAmt01022973
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0true
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt04
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InvestmentIncomeGrp/ExclusionAmt034109
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt034109
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt0846011
IRS990/InvestmentsPubTradedSecGrp/EOYAmt0896635
IRS990/IRPDocumentCnt013
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0MA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt0570091
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0THE ORGANIZATION'S PRIMARY MISSION IS TO SERVE SUBSCRIBERS AND THE GENERAL PUBLIC WITH EDUCATION, REVIEW AND PUBLICATION OF RESEARCH AND STUDY RESULTS OF DRUGS AND THE INTERACTION OF PHARMACEUTICALS.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt01223806
IRS990/NetAssetsOrFundBalancesEOYAmt01349797
IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt065024
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt065024
IRS990/NetUnrlzdGainsLossesInvstAmt0-28073
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherExpensesGrp/Desc0PAYROLL EXPENSE
IRS990/OtherExpensesGrp/Desc1MISCELLANEOUS
IRS990/OtherExpensesGrp/Desc2SUPPLIES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0770
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1166
IRS990/OtherExpensesGrp/ProgramServicesAmt0776
IRS990/OtherExpensesGrp/TotalAmt0776
IRS990/OtherExpensesGrp/TotalAmt1770
IRS990/OtherExpensesGrp/TotalAmt2166
IRS990/OtherWebsiteInd0X
IRS990/PartialLiquidationInd0false
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0380
IRS990/PrincipalOfficerNm0MICHAEL S MADDUX PHARMD FCCP
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0SUBSCRIPTION CONTRACT
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0353749
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0353749
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt061984
IRS990/PYOtherExpensesAmt0252468
IRS990/PYProgramServiceRevenueAmt0285430
IRS990/PYRevenuesLessExpensesAmt094946
IRS990/PYTotalExpensesAmt0252468
IRS990/PYTotalRevenueAmt0347414
IRS990/ReconcilationRevenueExpnssAmt0154064
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0true
IRS990/RelatedOrganizationCtrlEntInd0true
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt0353749
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0202059
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0210783
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt034109
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt030695
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt033912
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt023921
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt086294
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt0208931
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0353749
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0285430
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt0322192
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt0330831
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt0404296
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt01696498
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt034109
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt030695
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt033912
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt023921
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt086294
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt0208931
IRS990ScheduleA/InvestmentIncomeCYPct00.11000
IRS990ScheduleA/InvestmentIncomePYPct00.08000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.89030
IRS990ScheduleA/PublicSupportPY509Pct00.91710
IRS990ScheduleA/PublicSupportTotal509Amt01696498
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0353749
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0285430
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0322192
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0330831
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0404296
IRS990ScheduleA/Total509Grp/TotalAmt01696498
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0387858
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0316125
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0356104
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0354752
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0490590
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt01905429
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt011712
IRS990ScheduleD/ExpensesSubtotalAmt0287106
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt011712
IRS990ScheduleD/InvestmentExpensesNotIncldAmt011712
IRS990ScheduleD/NetUnrealizedGainsInvstAmt0-87421
IRS990ScheduleD/RevenueNotReportedAmt0-87421
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt011712
IRS990ScheduleD/RevenueSubtotalAmt0441170
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0UNCERTAIN TAX PROVISIONS, IF ANY, ARE RECORDED IN ACCORDANCE WITH FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ACCOUNTING STANDARDS CODIFICATION (ASC) 740, INCOME TAXES, WHICH REQUIRE THE RECOGNITION OF A LIABILITY FOR TAX POSITIONS TAKEN THAT DO NOT MEET THE MORE-LIKELY-THAN-NOT STANDARD THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY THE TAXING AUTHORITIES. THERE IS NO LIABILITY FOR UNCERTAIN TAX POSITIONS RECORDED AT DECEMBER 31. THE ORGANIZATION'S INCOME TAX FILINGS ARE SUBJECT TO EXAMINATION BY VARIOUS TAXING AUTHORITIES. THE ORGANIZATION'S OPEN EXAMINATION PERIODS ARE 2012 AND FORWARD.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0SCHEDULE D, PAGE 3, PART X
IRS990ScheduleD/TotalExpensesPerForm990Amt0298818
IRS990ScheduleD/TotalRevenuePerForm990Amt0452882
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt0353749
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt0287106
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE RETURN WILL BE REVIEWED BY THE FULL BOARD OF DIRECTORS. A COPY OF THE RETURN WILL BE MAINTAINED FOR PUBLIC INSPECTION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE ORGANIZATION REGULARLY MONITORS ONGOING OR PROPOSED TRANSACTIONS FOR CONFLICTS OF INTEREST AS IT RELATES TO THE BOARD OF DIRECTORS. THE POLICY PROHIBITS PARTICIPATION AND DELIBERATION AND DECISION MAKING OF ANY BOARD MEMBER AS IT RELATES TO A CONFLICT.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2GOVERNING DOCUMENTS ARE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST AND POSTED ON THE SECRETARY OF STATE WEBSITE OF THE COMMONWEALTH OF MASSACHUSSETS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3MANUSCRIPT SCIENTIFIC EDITING 21,000 0 0 ORIGINAL MANUSCRIPT FEES 42,000 0 0 DEVELOPMENT EDITOR & CONSULTI 34,215 0 0 CONSULTING 64,274 0 0 BOARD OF DIRECTORS 0 44,426 0 SCIENTIFIC EDITORS COMMITTEE 9,031 0 0 OVERHEAD 0 33,805 0 CONTRACTED SERVICES 24,333 8,111 0 TOTAL 194,853 86,342 0
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART IX, LINE 11G
IRS990ScheduleR/AssetExchangeInd0false
IRS990ScheduleR/AssetPurchaseFromOtherOrgInd0false
IRS990ScheduleR/AssetSaleToOtherOrgInd0false
IRS990ScheduleR/DivRelatedOrganizationInd0false
IRS990ScheduleR/GiftGrntCapContriFromOthOrgInd0false
IRS990ScheduleR/GiftGrntOrCapContriToOthOrgInd0false
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ControlledOrganizationInd0false
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DirectControllingNACd0N/A
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DisregardedEntityName/BusinessNameLine1Txt0AMERICAN COLLEGE OF CLINICAL PHARMA
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/EIN0431183142
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ExemptCodeSectionTxt0501C6
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/LegalDomicileStateCd0KS
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PrimaryActivitiesTxt0PROMOTE QU
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/AddressLine1Txt013000 W 87TH STREET PKWY
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/CityNm0LENEXA
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/StateAbbreviationCd0KS
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/ZIPCd066215
IRS990ScheduleR/LoansOrGuaranteesFromOthOrgInd0false
IRS990ScheduleR/LoansOrGuaranteesToOtherOrgInd0false
IRS990ScheduleR/PaidEmployeesSharingInd0false
IRS990ScheduleR/PerformOfServicesByOtherOrgInd0false
IRS990ScheduleR/PerformOfServicesForOthOrgInd0false
IRS990ScheduleR/ReceiptOfIntAnntsRntsRyltsInd0false
IRS990ScheduleR/ReimbursementPaidByOtherOrgInd0false
IRS990ScheduleR/ReimbursementPaidToOtherOrgInd0true
IRS990ScheduleR/RentalOfFacilitiesToOthOrgInd0false
IRS990ScheduleR/RentalOfFcltsFromOthOrgInd0false
IRS990ScheduleR/SharingOfFacilitiesInd0false
IRS990ScheduleR/TransactionsRelatedOrgGrp/InvolvedAmt033805
IRS990ScheduleR/TransactionsRelatedOrgGrp/OtherOrganizationName/BusinessNameLine1Txt0AMERICAN COLLEGE OF CLINICAL
IRS990ScheduleR/TransactionsRelatedOrgGrp/OtherOrganizationName/BusinessNameLine2Txt0PHARMACY
IRS990ScheduleR/TransactionsRelatedOrgGrp/TransactionTypeTxt0P
IRS990ScheduleR/TransferFromOtherOrgInd0false
IRS990ScheduleR/TransferToOtherOrgInd0false
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0MA
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt01238395
IRS990/TotalAssetsEOYAmt01370536
IRS990/TotalAssetsGrp/BOYAmt01238395
IRS990/TotalAssetsGrp/EOYAmt01370536
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt0103189
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0195629
IRS990/TotalFunctionalExpensesGrp/TotalAmt0298818
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt014589
IRS990/TotalLiabilitiesEOYAmt020739
IRS990/TotalLiabilitiesGrp/BOYAmt014589
IRS990/TotalLiabilitiesGrp/EOYAmt020739
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt01223806
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt01349797
IRS990/TotalProgramServiceExpensesAmt0195629
IRS990/TotalProgramServiceRevenueAmt0353749
IRS990/TotalRevenueGrp/ExclusionAmt034109
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0418773
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0452882
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt01238395
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt01370536
IRS990/TransactionWithControlEntInd0true
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UnrestrictedNetAssetsGrp/BOYAmt01223806
IRS990/UnrestrictedNetAssetsGrp/EOYAmt01349797
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt013000 WEST 87TH STEET PARKWAY
IRS990/USAddress/CityNm0LENEXA
IRS990/USAddress/StateAbbreviationCd0KS
IRS990/USAddress/ZIPCd066215
IRS990/VotingMembersGoverningBodyCnt05
IRS990/VotingMembersIndependentCnt04
IRS990/WebsiteAddressTxt0WWW.PHARMACOTHERAPY.ORG
IRS990/WhistleblowerPolicyInd0true
ReturnHeader/BuildTS02017-02-10 21:41:12Z
ReturnHeader/BusinessOfficerGrp/PersonNm0MICHAEL S MADDUX PHARMD FCCP
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0SECRETARY-TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum09134923311
ReturnHeader/BusinessOfficerGrp/SignatureDt02017-04-26
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PHARMACOTHERAPY PUBLICATIONS INC
ReturnHeader/Filer/BusinessNameControlTxt0PHAR
ReturnHeader/Filer/EIN0042720360
ReturnHeader/Filer/PhoneNum09134923311
ReturnHeader/Filer/USAddress/AddressLine1Txt013000 WEST 87TH STREET PARKWAY
ReturnHeader/Filer/USAddress/CityNm0LENEXA
ReturnHeader/Filer/USAddress/StateAbbreviationCd0KS
ReturnHeader/Filer/USAddress/ZIPCd066215
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId087E6E23A3DA0DB3DAA29BB9D86E8B3430BB23E8A
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId0A2517DCF272615E9274DAFEB5A9825ABB5CF7997
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0481142819
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0BRIDGEBUILDER TAX LEGAL SERVICES PA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt09325 PFLUMM RD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0LENEXA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0KS
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0662153347
ReturnHeader/PreparerPersonGrp/PhoneNum09134926008
ReturnHeader/PreparerPersonGrp/PreparationDt02017-11-09
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0KENNETH L COX
ReturnHeader/ReturnTs02017-11-10T16:18:39-06:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02016-01-01
ReturnHeader/TaxPeriodEndDt02016-12-31
ReturnHeader/TaxYr02016

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2016 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$1,370,536
Liabilities
$20,739
Net assets
$1,349,797
Revenue
$452,882
Expenses
$298,818
Net income
$154,064
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$5.24$0.23$5.01$0.65$0.58$0.07
2023Detailed filing. Detailed filing data is available for this year.$1.56$0.07$1.50$0.41$0.48$0.07
2022Detailed filing. Detailed filing data is available for this year.$1.47$0.10$1.37$0.43$0.43$0.01
2021Detailed filing. Detailed filing data is available for this year.$1.75$0.12$1.63$0.43$0.40$0.03
2020Detailed filing. Detailed filing data is available for this year.$1.61$0.15$1.47$0.37$0.35$0.02
2019Detailed filing. Detailed filing data is available for this year.$1.51$0.19$1.32$0.38$0.44$0.06
2018Detailed filing. Detailed filing data is available for this year.$1.42$0.22$1.20$0.41$0.43$0.03
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.64$0.25$1.38$0.39$0.38$0.01
2016Detailed filing. Detailed filing data is available for this year.$1.37$0.02$1.35$0.45$0.30$0.15
2015XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.24$0.01$1.22$0.35$0.25$0.09
2014Detailed filing. Detailed filing data is available for this year.$1.21$0.03$1.18$0.39$0.22$0.17
2013Detailed filing. Detailed filing data is available for this year.$1.04$0.01$1.03$0.38$0.20$0.18
2012Summary only. Only limited summary data is available for this year.$0.89$0.10$0.79$0.42$0.70$0.28
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.08$0.05$1.03$1.00
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.24$0.19$1.05$0.98